Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 424B3 Offering Prospectus
  2. 8-K Event Executive or director change · Other events
  3. 4 Open-market sale 10% owner sold 445,712 shares at an average $0.68 ($303,910)
  4. SC 13D Stake Beneficial Ownership Report
  5. 4/A Open-market buy Chief Scientist bought 100,000 shares at $0.58 ($58,000)
  6. 4 Open-market buy Chief Scientist bought 100,000 shares at $58.00 ($5,800,000)
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 424B3 Offering Prospectus
  10. 8-K Event Other events
  11. 8-K Event Executive or director change
  12. 424B3 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. 424B5 Offering Prospectus
  15. 424B5 Offering Prospectus
  16. EFFECT Other Notice of Effectiveness
  17. EFFECT Other Notice of Effectiveness
  18. POS AM Other Post-effective Amendment for Registration Statement
  19. POS AM Other Post-effective Amendment for Registration Statement
  20. 10-K/A Report 10-K/A

Page 12 of 24 · 479 filings